Debt-to-equity of Actinium Pharmaceuticals, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Actinium Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Actinium Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 190%, a 72% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Actinium Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 190% +79% +72% 30 Sep 2025
Q2 2025 151% +43% +40% 30 Jun 2025
Q1 2025 126% +24% +23% 31 Mar 2025
Q4 2024 113% +17% +18% 31 Dec 2024
Q3 2024 111% +27% +33% 30 Sep 2024
Q2 2024 108% +34% +45% 30 Jun 2024
Q1 2024 102% +36% +54% 31 Mar 2024
Q4 2023 95% +45% +90% 31 Dec 2023
Q3 2023 83% +49% +139% 30 Sep 2023
Q2 2023 74% +54% +270% 30 Jun 2023
Q1 2023 67% +60% +874% 31 Mar 2023
Q4 2022 50% +44% +689% 31 Dec 2022
Q3 2022 35% +29% +481% 30 Sep 2022
Q2 2022 20% +13% +180% 30 Jun 2022
Q1 2022 6.8% -1.8% -21% 31 Mar 2022
Q4 2021 6.3% -6.6% -51% 31 Dec 2021
Q3 2021 6% -15% -71% 30 Sep 2021
Q2 2021 7.2% -26% -78% 30 Jun 2021
Q1 2021 8.6% -61% -88% 31 Mar 2021
Q4 2020 13% -57% -81% 31 Dec 2020
Q3 2020 21% -43% -68% 30 Sep 2020
Q2 2020 33% -23% -41% 30 Jun 2020
Q1 2020 70% +18% +34% 31 Mar 2020
Q4 2019 69% +33% +89% 31 Dec 2019
Q3 2019 64% +32% +101% 30 Sep 2019
Q2 2019 56% +28% +100% 30 Jun 2019
Q1 2019 52% +22% +74% 31 Mar 2019
Q4 2018 37% +3.8% +11% 31 Dec 2018
Q3 2018 32% +1.5% +5.1% 30 Sep 2018
Q2 2018 28% -3.5% -11% 30 Jun 2018
Q1 2018 30% +5.9% +25% 31 Mar 2018
Q4 2017 33% +14% +77% 31 Dec 2017
Q3 2017 30% +12% +70% 30 Sep 2017
Q2 2017 32% +17% +111% 30 Jun 2017
Q1 2017 24% +9.1% +62% 31 Mar 2017
Q4 2016 19% +2.8% +18% 31 Dec 2016
Q3 2016 18% -12% -41% 30 Sep 2016
Q2 2016 15% -51% -77% 30 Jun 2016
Q1 2016 15% -147% -91% 31 Mar 2016
Q4 2015 16% 31 Dec 2015
Q3 2015 30% 30 Sep 2015
Q2 2015 66% 30 Jun 2015
Q1 2015 162% 31 Mar 2015
Q4 2012 583% 31 Dec 2012
Q3 2012 55% 30 Sep 2012
Q2 2012 50% 30 Jun 2012
Q1 2012 46% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.